GLP-1s tied to elevated risk of fainting, dizziness

Northwestern Medicine scientists have identified a safety concern associated with GLP-1 drugs. Using health record data, the research team tracked more than 42,000 adults already taking at least two types of blood pressure ...

FDA approves rapid-acting inhaled insulin for children

The U.S. Food and Drug Administration has approved Afrezza (insulin human) Inhalation Powder for use in children and adolescents aged 6 years and older who are living with type 1 or type 2 diabetes.

Researchers uncover new details in type 2 diabetes development

Researchers at the Ohio University Heritage College of Osteopathic Medicine have discovered new information about how type 2 diabetes develops and how future treatments may help protect insulin-producing cells in the pancreas. ...

Diabetes tied to higher tooth and implant loss over 10 years

Diabetes is associated with complications in multiple organs, including the oral cavity. As a group, people with type 1 or type 2 diabetes are at higher risk for oral diseases. According to a new thesis by dentist Anna Trullenque ...

page 5 from 40